Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Bisserier

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|June 17, 2025
Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertensionElizabeth Singh, Malik Bisserier
Circulation Research|January 2, 2026
ADAR1-Mediated RNA Editing Regulates Innate Immunity in Pulmonary HypertensionYuanjun Shen, Malik Bisserier
Blood|March 25, 2018
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomasMalik Bisserier, Narendra Wajapeyee
Journal of Cellular Immunology|June 27, 2020
Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary FibrosisMalik Bisserier, Lahouaria Hadri
Cells|April 3, 2021
Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial HypertensionShahood Fazal, Malik Bisserier, Lahouaria Hadri
Reviews in Cardiovascular Medicine|July 25, 2020
Current and emerging therapeutic approaches to pulmonary hypertensionMalik Bisserier, Natasha Pradhan, Lahouaria Hadri
Biochemical Society Transactions|March 21, 2014
Epac proteins: specific ligands and role in cardiac remodellingMalik Bisserier, Jean-Paul Blondeau, Frank Lezoualc'h
Vascular Biology (Bristol, England)|March 13, 2020
Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension diseaseMalik Bisserier, Radoslav Janostiak, Frank Lezoualc'h, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2022
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent ModelsMalik Bisserier, Olivier Boucherat, Sebastien Bonnet, et al.
Biomedicines|January 26, 2024
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial HypertensionKatherine Jankowski, Vineeta Jagana, Malik Bisserier, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|June 17, 2025
Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertensionElizabeth Singh, Malik Bisserier
Circulation Research|January 2, 2026
ADAR1-Mediated RNA Editing Regulates Innate Immunity in Pulmonary HypertensionYuanjun Shen, Malik Bisserier
Blood|March 25, 2018
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomasMalik Bisserier, Narendra Wajapeyee
Journal of Cellular Immunology|June 27, 2020
Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary FibrosisMalik Bisserier, Lahouaria Hadri
Cells|April 3, 2021
Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial HypertensionShahood Fazal, Malik Bisserier, Lahouaria Hadri
Reviews in Cardiovascular Medicine|July 25, 2020
Current and emerging therapeutic approaches to pulmonary hypertensionMalik Bisserier, Natasha Pradhan, Lahouaria Hadri
Biochemical Society Transactions|March 21, 2014
Epac proteins: specific ligands and role in cardiac remodellingMalik Bisserier, Jean-Paul Blondeau, Frank Lezoualc'h
Vascular Biology (Bristol, England)|March 13, 2020
Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension diseaseMalik Bisserier, Radoslav Janostiak, Frank Lezoualc'h, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2022
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent ModelsMalik Bisserier, Olivier Boucherat, Sebastien Bonnet, et al.
Biomedicines|January 26, 2024
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial HypertensionKatherine Jankowski, Vineeta Jagana, Malik Bisserier, et al.
Pageof 7